Vantage Biosciences

📍 London, United Kingdom🗓 Founded 2023👥 4 employees
Biotechnology Research🌐 vantage-biosciences.com
Website LinkedIn
Vantage Biosciences is a UK-based clinical stage biotechnology company targeting the root cause of vision loss resulting from diabetes – the neuroinflammatory insult that precedes microangiopathy and leads to degeneration of the neurovascular unit of the eye. Our mission is to enable patient access to disease modifying therapy for diabetic eye disease by developing drugs that intervene at the earliest point of disease biology.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Vantage Biosciences founded?
Vantage Biosciences was founded in 2023.
What industry is Vantage Biosciences in?
Vantage Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Vantage Biosciences based?
Vantage Biosciences is headquartered in London, United Kingdom.